The agency is still unclear about where it will stand on clinical trial diversity, but companies are looking for answers and ...

There is an emerging but erroneous theory that diversity, equity, and inclusion (DEI) initiatives are at odds with the ...

Spokespeople for Eli Lilly, Bristol Myers Squibb, Sanofi and Roche’s Genentech confirmed in emails to Fierce Biotech that their work on advancing clinical trial diversity remains ongoing.

Clinical trials are the foundation of modern medicine, shaping the treatments and therapies that improve and save lives.

Inclusion of female and Hispanic/Latino patients has increased over time, but most trials of metabolic dysfunction-associated ...

While many pharma companies are actively working on initiatives to improve diversity in clinical trials, we still have a long way to go. The good news is that technology is being harnessed to ...

Explore the barriers Black women face in clinical trials and learn how to increase participation, trust, and diversity in medical research.

Clinical research continues to struggle with a lack of representation within trial populations, and gender diversity in clinical trials remains a critical issue. The theme for this year’s ...

Columbia researchers believe their grants are being cut because of diversity components that were imposed by the federal ...

and it is the responsibility of the researcher to build the trust needed to increase diversity in these trials, the panel agreed. Kwatra told the audience he often makes a point to have a personal ...

Over the past decade, a number of medicines regulators, including in SwitzerlandExternal link, have created guidance, toolkits and standards for more diversity in clinical trials. The importance ...

“You don’t fully understand whether sub-populations will benefit in the same way as those involved in the trials do.” Campbell is an author of “Investigator Racial Diversity and Clinical Trial ...